Drug Repurposing Advances, Scopes and Opportunities in Drug Discovery

Drug repurposing (or drug repositioning) is defined as the process of identifying new pharmacological indications of old, existing, investigational, or FDA-approved drugs for use in the treatment of diseases other than the drugs' original intended therapeutic use. Drug Repurposing - Advances, S...

Full description

Saved in:
Bibliographic Details
Other Authors: Rudrapal, Mithun (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_113401
005 20230905
003 oapen
006 m o d
007 cr|mn|---annan
008 20230905s2023 xx |||||o ||| 0|eng d
020 |a intechopen.106301 
020 |a 9781837687770 
020 |a 9781837687763 
020 |a 9781837687787 
040 |a oapen  |c oapen 
024 7 |a 10.5772/intechopen.106301  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MMG  |2 bicssc 
100 1 |a Rudrapal, Mithun  |4 edt 
700 1 |a Rudrapal, Mithun  |4 oth 
245 1 0 |a Drug Repurposing  |b Advances, Scopes and Opportunities in Drug Discovery 
260 |b IntechOpen  |c 2023 
300 |a 1 electronic resource (224 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Drug repurposing (or drug repositioning) is defined as the process of identifying new pharmacological indications of old, existing, investigational, or FDA-approved drugs for use in the treatment of diseases other than the drugs' original intended therapeutic use. Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery delivers up-to-date information on the identification of newer uses, molecular mechanisms, and novel targets of existing drug candidates through the application of various experimental, biophysical, and computational approaches and techniques. Chapters discuss recent advances in drug repurposing strategies that are currently being used in the discovery and development of drugs against difficult-to-treat, rare, and life-threatening diseases, including microbial infections, COVID-19, parasitic diseases, cardiovascular diseases, neurological disorders, and cancer. The book also discusses the modern experimental assays (HTS) and computational techniques including informatics and databases, molecular docking and dynamics, artificial intelligence and machine learning, virtual screening and pharmacophore modeling, proteomics and metabolomics, and network pharmacology and systems biology approaches. Some of the key features of the book are: • Presents the strategies available for the development of drugs by drug repurposing approaches through various experimental and computational techniques for the treatment of difficult-to-treat, rare, and deadly diseases • Summarizes the latest advances in the application of drug repurposing strategies, techniques, and approaches in the discovery and development of drugs • Depicts drug development approaches from existing drug candidates and/or lead molecules through modern experimental assays, biophysical tools, and computational techniques Written by a global team of experts, this book is useful for drug discovery scientists, drug developers, medicinal chemists, phytochemists, pharmacologists, clinicians, biochemists, biomedical scientists, healthcare professionals, researchers, teaching faculty, and students. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Pharmacology  |2 bicssc 
653 |a covid-19 
653 |a cancer 
653 |a machine learning 
653 |a big data 
653 |a angiogenesis 
653 |a screening 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/12445/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/113401  |7 0  |z DOAB: description of the publication